GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (STU:7W3) » Definitions » Return-on-Tangible-Asset

Acotec Scientific Holdings (STU:7W3) Return-on-Tangible-Asset : 1.51% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Acotec Scientific Holdings's annualized Net Income for the quarter that ended in Dec. 2024 was €3.23 Mil. Acotec Scientific Holdings's average total tangible assets for the quarter that ended in Dec. 2024 was €214.10 Mil. Therefore, Acotec Scientific Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 was 1.51%.

The historical rank and industry rank for Acotec Scientific Holdings's Return-on-Tangible-Asset or its related term are showing as below:

STU:7W3' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -23.42   Med: 2.08   Max: 20.72
Current: 3.18

During the past 6 years, Acotec Scientific Holdings's highest Return-on-Tangible-Asset was 20.72%. The lowest was -23.42%. And the median was 2.08%.

STU:7W3's Return-on-Tangible-Asset is ranked better than
62.28% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -1 vs STU:7W3: 3.18

Acotec Scientific Holdings Return-on-Tangible-Asset Historical Data

The historical data trend for Acotec Scientific Holdings's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings Return-on-Tangible-Asset Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Return-on-Tangible-Asset
Get a 7-Day Free Trial -22.86 -10.22 5.12 0.94 3.28

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.63 2.91 -0.98 4.84 1.51

Competitive Comparison of Acotec Scientific Holdings's Return-on-Tangible-Asset

For the Medical Devices subindustry, Acotec Scientific Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acotec Scientific Holdings's Return-on-Tangible-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acotec Scientific Holdings's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Acotec Scientific Holdings's Return-on-Tangible-Asset falls into.


;
;

Acotec Scientific Holdings Return-on-Tangible-Asset Calculation

Acotec Scientific Holdings's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=6.857/( (206.191+211.698)/ 2 )
=6.857/208.9445
=3.28 %

Acotec Scientific Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2024 )  (Q: Jun. 2024 )(Q: Dec. 2024 )
=3.232/( (216.5+211.698)/ 2 )
=3.232/214.099
=1.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2024) net income data.


Acotec Scientific Holdings  (STU:7W3) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Acotec Scientific Holdings Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Acotec Scientific Holdings Business Description

Traded in Other Exchanges
Address
16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions.

Acotec Scientific Holdings Headlines

No Headlines